amoxicillin + clavulanic acid + fluconazole + levofloxacin

This is a combination of four pharmaceutical agents—amoxicillin, clavulanic acid, fluconazole, and levofloxacin.

• Amoxicillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis.
• Clavulanic acid is a beta-lactamase inhibitor that protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria.
• Fluconazole is an antifungal agent (not described in the provided search results but widely known) that inhibits fungal cytochrome P450 enzyme 14α-demethylase, disrupting ergosterol synthesis and thus fungal cell membrane formation.
• Levofloxacin is a broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, essential for DNA replication and repair.

This combination would provide broad antibacterial coverage (including Gram-positive and Gram-negative bacteria) as well as antifungal activity. There are no known approved or marketed products containing all four agents together; such combinations may be used in specific clinical scenarios under medical supervision.